Trusted Digital Evidence for Regulatory Approval
Bringing a new drug to market can cost up to $2.5 billion and take 15 years.
It’s no surprise that the use of simulation for regulatory approval is on the rise to establish the safety and efficacy of medical devices or treatments.
Computational modeling is being used more frequently in the design of medical devices and pharmaceutical equipment. These simulations accelerate innovation and provide comprehensive evidence of long-term safety.
- Simulation-driven regulatory approval
- In silico (non clinical) trials
- In silico clinical trials
- Virtual patients
- Medical digital twins
“Without simulation, our development timelines would be extended by years and costs increased by millions of dollars.”
Mike Hess, VP of Corporate Technology and Innovation, Medtronic
Faster FDA Approvals with Ansys
Benefits of Ansys Simulation Technology for Medical Device Development
Get started with Ansys software.
KETIV + Ansys
KETIV has partnered with Ansys to deliver a prototyping platform that enables multispecialty teams with diverse engineering backgrounds to work in unison.
Ansys’ simulation solutions enable medical device manufacturers to gain more insightful data than is typically possible with physical testing. The result is more rapid prototyping, integrated designs that function from day one and the ability to fix operational problems before going into the physical testing phase.